A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19.

Wuxia Yang,Yichao Zhang, Jing Gao,Pengcheng Hu,Yanjie Yang,Xiaoqing Xu

Frontiers in medicine（2023）

引用 0|浏览2

暂无评分

摘要

The efficacy and quality of life of the Zilongjin tablets combined conventional chemotherapy for NSCLC were significantly better than chemotherapy alone, alleviating various adverse effects. At the same time, the Zilongjin tablets may modulate the inflammatory response to alleviate NSCLC and COVID-19.

查看译文

关键词

zilongjin tablets,cell lung cancer,lung cancer,network pharmacology,meta-analysis,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要